Business Context and Reporting Period
This Form 6-K filing by EUDA Health Holdings Ltd covers the month of March 2026. The report details a corporate action approved by the Board of Directors: a 1-for-20 reverse stock split of the Company's ordinary shares, effective March 23, 2026, on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments.
- Shares Outstanding (Pre-Split): Approximately 50,307,491
- Shares Outstanding (Post-Split): Approximately 2,515,375
- Warrants Outstanding: 8,917,250
- Warrant Exercise Price (Pre-Split): $11.50 per share
- Warrant Exercise Price (Post-Split): $230.00 per share
- New CUSIP: G3142E147
Material Changes
The primary material change is the reduction of outstanding ordinary shares by a factor of 20. Fractional shares resulting from the split will be rounded up to the nearest whole share, with no cash paid for fractional interests. Warrant terms have been proportionately adjusted to maintain economic equivalence.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future operations, or discussion of risks and contingencies. The document states that stockholder percentage ownership and voting power will remain substantially unchanged, except for minor adjustments due to fractional share rounding.
Investor Verification Checklist
- Confirm the effective trading date of the reverse stock split (March 23, 2026).
- Verify the new CUSIP number (G3142E147) for trading purposes.
- Check the adjusted warrant exercise price ($230.00) and share entitlement (1/40th share per warrant).
- Review the treatment of fractional shares (rounded up, no cash payout).